<DOC>
	<DOCNO>NCT00034463</DOCNO>
	<brief_summary>This non-randomized , phase 1 , study primary objective determine toxicity establish maximum tolerate dose ALIMTA administer 10 minute infusion every 21 day folic acid multi-vitamin supplementation therapy lightly heavily pre-treated patient locally advanced metastatic cancer .</brief_summary>
	<brief_title>ALIMTA ( Pemetrexed ) Patients With Locally Advanced Metastatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>Histologic cytologic diagnosis metastatic locally advanced cancer Prior chemotherapy allow Adequate bone marrow , liver kidney function Prior treatment ALIMTA Brain metastasis Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>metastatic cancer</keyword>
	<keyword>chemotherapy</keyword>
</DOC>